2024 Louisiana Revised Statutes 40:1081.1 – Programs for combating phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell diseases, biotinidase deficiency, and other genetic conditions

2023 Louisiana Revised Statutes 40:1081.1 – A. The Louisiana Department of Health is hereby authorized and directed to establish, maintain, and carry out programs designed to reduce mortality and morbidity from sickle cell dis

2022 Louisiana Revised Statutes 40:1081.1 – A. The Louisiana Department of Health is hereby authorized and directed to establish, maintain, and carry out programs designed to reduce mortality and morbidity from sickle cell dis

2021 Louisiana Revised Statutes 40:1081.1 – A. The Louisiana Department of Health is hereby authorized and directed to establish, maintain, and carry out programs designed to reduce mortality and morbidity from sickle cell dis

2020 Louisiana Revised Statutes 40:1081.1 – A. The Louisiana Department of Health is hereby authorized and directed to establish, maintain, and carry out programs designed to reduce mortality and morbidity from sickle cell dis

2019 Louisiana Revised Statutes 40:1081.1 – A. The Louisiana Department of Health is hereby authorized and directed to establish, maintain, and carry out programs designed to reduce mortality and morbidity from sickle cell dis